Validation of a Smartphone Application for the Assessment of Patients With Mild Cognitive Impairment: MemScreen

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03811184

Acronym

MemScreen

Enrollment

400

Registered

2019-01-22

Start date

2019-01-17

Completion date

2020-06-30

Last updated

2019-08-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer Disease, Cognitive Impairment

Brief summary

The clinical evaluation of a patient with a cognitive complaint requires neuropsychological tests, evaluating the integrity of memory and other cognitive functions. The initial evaluation is made most often by a doctor (general practitioner). In case of need for further examination, a neuropsychological report is made in consultation memory by a neuropsychologist, with further cognitive tests. The Cognitive Neurology Center at Lariboisière Hospital - Fernand Widal has developed a tool on a digital tablet or smartphone to evaluate cognitive functions: MemScreen. The purpose of this study is to validate this new neuropsychological test on tablet compared to the neuropsychological reference tests.

Detailed description

Characteristics of MemScreen : * Smartphone / tablet application developed by the Cognitive Neurology Center at Lariboisière - Fernand Widal Hospital to explore a patient with a cognitive disorder. * The application is a self-test by the patient under the supervision of a doctor. * The doctor has an account to be able to pass the test to patients. * The tablet test is anonymous without the possibility to identify the patient.

Interventions

DIAGNOSTIC_TESTMemScreen

Neuropsychological test on smartphone or digital tablet, on self assesment.

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

40 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* Major patients followed in memory clinic. * Performing a neuropsychological assessment less than 6 months old. * No visual or motor deficiency impeding the use of a digital tablet.

Exclusion criteria

* None.

Design outcomes

Primary

Measure	Time frame	Description
Ability to detect patients with mild cognitive impairment.	through study completion, an average of 6 months	To evaluate the ability of MemScreen to discriminate patients with an objective memory disorder from a validated neuropsychological reference test: the free and cued selective reminding test.

Countries

France

Contacts

Primary ContactJulien Dumurgier, MD

julien.dumurgier@aphp.fr0033140054313

Backup ContactClaire Paquet, MD

claire.paquet@inserm.fr0033140054313

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026